MicroSynbiotiX, founded in 2016 in Cork, is a biotech startup aiming to revolutionize the production of economical vaccines and therapeutic proteins through its algal platform technology. Leveraging the latest advancements in algal genomics and molecular biology, the company plans to engineer microalgae to produce cost-effective therapeutic proteins and vaccines with significant economic potential. The last investment, a convertible note, took place on 24 October 2019 and was secured from SOSV and RebelBio. With its innovative approach to biotechnology, MicroSynbiotiX is poised to make substantial contributions to the healthcare industry.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Convertible Note | Unknown | 2 | RebelBio | 24 Oct 2019 |
Convertible Note | Unknown | 2 | RebelBio | 23 Nov 2018 |
Seed Round | €1.00M | 5 | RebelBio | 05 Sep 2017 |
Convertible Note | Unknown | 2 | RebelBio | 30 Jan 2017 |
Grant | €150.00K | - | 25 Jan 2017 |
No recent news or press coverage available for Microsynbiotix, Ltd..